TERT and hepatocellular carcinoma: Interestingly, the mutant genotypes of the TERT (rs2736098*A/A and rs2736100*T/T) were considerably elevated among HCC patients compared with control subjects [TERT (rs2736098*A/A): 16.7% vs. 8.0%, OR = 3.97, 95% CI = 1.60–9.89, p-value = 0.003; and TERT (rs2736100*T/T): 35.2% vs. 22.4%, OR = 2.30, 95% CI = 1.13–4.68, p-value = 0.023, respectively], (Table 2).